Real stories, artificial authors.
Articles related to ultragenyx
Ultragenyx said it agreed to sell a rare pediatric disease priority review voucher tied to gene therapy FAYUVI for $203M, its second PRV sale this month.
$RARE, #biotech, #ultragenyx, #prv, #raredisease